Accelerating Respiratory Clinical Development

An India Network Delivering:

Reach

Expertise

Execution

The InoRx Respiratory Clinical Research Network gives sponsors regulatory-ready access to pulmonology, critical care, thoracic surgery, allergy, and multispecialty hospitals across India. The network supports Phase I–IV trials across chronic respiratory disease, pulmonary disorders, inhalation therapies, respiratory devices, and respiratory biologics — backed by experienced investigators, advanced diagnostics, and centralized operational oversight.
Contact Us
Download Fact Sheet

The Network at a Glance

12,000+

Respiratory patients diagnosed every month across network sites

150,000+

Respiratory patients accessible annually, network-wide

50+

Qualified respiratory clinical research sites across India

 A Respiratory Network Built for High-Volume, Complex Trials Across India

Respiratory programs demand large, diverse patient pools and specialized diagnostic infrastructure at the same time. InoRx combines a high-volume site network with centralized recruitment analytics and standardized execution — so sponsors get predictable enrollment without sacrificing data quality or regulatory readiness.

Reach

Broad geographic coverage across India’s leading healthcare hubs, with access to urban, semi-urban, and rural patient populations across the country’s major respiratory disease burden regions.
  • Access to 12,000+ respiratory patients diagnosed monthly
  • 50+ qualified respiratory clinical research sites nationwide
  • Scalable site activation based on protocol requirements, recruitment targets, and sponsor timelines

Expertise

Investigators with deep experience across every respiratory subspecialty, supported by established referral pathways between pulmonologists, critical care physicians, thoracic surgeons, and allergists.
  • Pulmonology, Respiratory Medicine, Critical Care Medicine, Thoracic Surgery, Allergy & Clinical Immunology, Internal Medicine, and Sleep Medicine (selected centers)
  • Access to both treatment-naive and therapy-experienced patients
  • Experience in multicenter global trials, investigator-initiated studies, and post-marketing research

Execution

Centralized operational oversight standardizes execution across every participating site, reducing variability and accelerating start-up.
  • Centralized feasibility assessments using recruitment analytics and site intelligence
  • Parallel site activation strategies to reduce study start-up timelines
  • Risk-based operational oversight aligned with ICH-GCP

Every Respiratory Indication. One Coordinated Network.

From asthma and COPD to interstitial lung disease and respiratory failure, InoRx’s India operations cover the full respiratory spectrum — one team, one contract, one accountable partner.

Indications supported

  • Asthma
  • Severe Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • COPD Exacerbations
  • Interstitial Lung Disease (ILD)
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Bronchiectasis
  • Pulmonary Hypertension
  • Sleep-Related Breathing Disorders
  • Respiratory Failure
  • Inhalation Therapies
  • Respiratory Medical Devices

Trial types supported

  • Phase I–IV Interventional Trials
  • Respiratory Biologics
  • Small Molecule Therapies
  • Biosimilars
  • PK/PD Studies
  • Observational Studies
  • Patient Registries
  • Post-Marketing Studies

Note: Respiratory infectious disease studies (Influenza, COVID-19, RSV, Tuberculosis, Community-Acquired Pneumonia) can additionally draw on the InoRx Virology & Infectious Disease Clinical Research Network.

 Infrastructure and Quality Sponsors Can Build a Protocol Around

From first-in-human studies to large-scale post-marketing registries, InoRx delivers across the full clinical development spectrum.

Advanced Pulmonary Diagnostics

Protocol-specific respiratory diagnostic capability at participating sites, including Pulmonary Function Testing (PFT), Spirometry with Bronchodilator Reversibility Testing, DLCO (selected centers), HRCT, Bronchoscopy/BAL, Six-Minute Walk Test, and Arterial Blood Gas analysis.

Critical Care & Complex Study Capability

ICU and High Dependency Units, non-invasive and mechanical ventilation support, sleep laboratories with overnight polysomnography (selected centers), and cold-chain/biospecimen logistics for complex, high-acuity protocols.

Regulatory & Quality Readiness

Experience supporting CDSCO, US FDA, and EMA submissions across ICH-GCP compliant, inspection-ready sites with centralized quality oversight and risk-based monitoring.

From Feasibility to Database Lock. A Standardized Path.

Centralized oversight eliminates handoff friction at every stage of a respiratory trial.

Feasibility & Site Intelligence

Centralized feasibility assessments built on recruitment analytics and site-level intelligence.

Investigator & Site Selection

Sites and investigators selected on patient availability, therapeutic expertise, infrastructure, and prior study performance.

Parallel Site Activation

Standardized pre-screening and feasibility processes support rapid, parallel activation across the network.

Recruitment & Study Execution

High-volume referral centers and dedicated disease-specific clinics (Asthma, COPD, ILD, Pulmonary Fibrosis, Bronchiectasis) drive enrollment.

Oversight & Data Integrity

Continuous, risk-based oversight of recruitment, quality, compliance, and data integrity through database lock.

Clinical Infrastructure & Patient Access

Percentage of network sites with clinical experience by indication
Asthma
100%
COPD
100%
Inerstitial Lung Disease (ILD)
83%
Sleep-related Breathing Disorders
85%
Idiopathic Pulmonary Fibrosis (IPF)
Available at selected specialist centers
Bronchiectasis
Available at selected specialist centers
Pulmonary Hypertension
Available at selected specialist centers
Coverage represents the percentage of participating network sites with therapeutic area experience.

Key Respiratory Clinical Trial Sites Across India

A geographically distributed network spanning 12 states, combining private and government healthcare institutions.
STATE
GOVERNMENT
PRIVATE
TOTAL
Total
105
245
350
Andhra Pradesh
24
5
29
Gujarat
—
39
39
Karnataka
9
22
31
Kerala
2
14
16
Maharashtra
9
84
93
New Delhi
3
29
32
Haryana
4
7
11
Assam / Bihar / Chhattisgarh / J&K / Odisha
—
—
9

Start Your Respiratory Program in India Today

Talk to our respiratory team about your protocol, indication, and timeline.

Download Fact Sheet